Loading clinical trials...

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study | Clinical Trials | Clareo Health

WITHDRAWNPhase 3NCT00230373

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

Localized scleroderma or morphea is a fibrotic disease, imiquimod induces cytokines which inhibit fibrotic activity . We propose that topical imiquimod 5% cream is efficacious and safe in treating pla...

Lead sponsor: University of Alberta•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

NCT01808937 · Scleroderma, Localized, Morphea, and more

WITHDRAWNPhase 1/2

Study to Assess Sarilumab in Halting Progression of Morphea

NCT03679845 · Morphea, Plaque Form

COMPLETEDPhase 2

Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

NCT03351114 · Morphea

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 23, 2015Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE3

Enrollment—

Start dateNov 2005

Last updatedApr 23, 2015

Condition

Morphea

Locations shown

Dr. Marlene Dytoc's clinic

Edmonton, Alberta

University of Alberta

Edmonton, Alberta

Dr. Loretta Fiorillo's clinic

Red Deer, Alberta

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 23, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions